A screening project of diabetics with a very high cardiovascular risk (e.g. diabetes plus coronary heart disease) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is \<70mg/dl for such patients with very high risk) are screened. The doctors therapy decisions after the screening will be documented and 8-10 weeks later the lipid profile of each patient will be evaluated again. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.
Study Type
OBSERVATIONAL
Enrollment
685
Research Site
Vienna, Austria
Cholesterol levels
Cholesterol levels from high risk patients after 4 weeks of cholesterol-lowering drug therapy under target values
Time frame: After 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.